Vigilance against pyrexia
Home » News » Company News » Vigilance against pyrexia

Vigilance against pyrexia

Publish Time: 2023-07-20     Origin: Site

       Pyrexia triggers direct coagulation and fibrinolytic abnormalities, and finally leads to the development of disseminated intravascular coagulation ( DIC ). The Chinese Expert Consensus on Diagnosis and Treatment of Pyrexia mentions that elevated TAT and PIC, TM, and t-PAIC can be used to more intuitively monitor the early stage of DIC and the staging and typing of DIC, and provide an effective basis for the diagnosis and treatment of complex coagulopathies in patients with pyrexia. Pyrexia also causes systemic inflammatory reaction and internal environment disorder, which will increase the concentration of IL-6 and cause metabolic acidosis, etc. IL-6 test can be used to determine the severity of inflammation in patients with pyrexia.

       By linking the three major technology platforms of chemiluminescence, electrochemistry and immunofluorescence, we can provide a more comprehensive overall solution for pyrexia.


Our company focuses on the research, development, production, sales and related biochemical of in vitro diagnostic reagents, and specializes in the production and supply of IVD medical related supplies.

CONTACT US

  +86 -91-4324182
     +86-158-0991-7255
  gracie@yufubio.com.cn
  Room 607, Buliding B, Tianhe New City Square, No.38 East Henan Road, New Urban District, Urumqi, Xinjiang, P.R. China

SEARCH PRODUCT

​Copyright ©  2023 Yufu Biotech Co., Ltd |  Sitemap | Supported by leadong